Skip to main content
Clinical Trials/NCT04140682
NCT04140682
Completed
Not Applicable

Comparison of Proportional Assisted Ventilation and Pressure Support Ventilation in Adult Patients With Prolonged Mechanical Ventilation: A Randomized Controlled Trial

Kaohsiung Veterans General Hospital.1 site in 1 country44 target enrollmentMay 1, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Respiratory Failure
Sponsor
Kaohsiung Veterans General Hospital.
Enrollment
44
Locations
1
Primary Endpoint
28-day weaning success rate
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

A prospective randomized controlled trial was conducted to collect patients with prolonged mechanical ventilation. Patients were randomly assigned to receive PAV+ or PSV as weaning mode. Weaning outcomes were compared between 2 groups.

Detailed Description

Pressure support ventilation (PSV) the most frequently used mode of ventilator support in intensive care units, but has several demerits. Proportional assist ventilation with load-adjustable gain factors (PAV+) is a promising mode with better patient synchrony and weaning advantages. However, weaning outcome of PAV+ in patients with prolonged mechanical ventilation has not been evaluated before. We conducted a prospective randomized controlled trial in a tertiary medical center. This study aimed to compare the effectiveness between PAV+ and PSV for weaning adult patients with prolonged mechanical ventilation.

Registry
clinicaltrials.gov
Start Date
May 1, 2010
End Date
April 30, 2011
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Chiu-Fan Chen

Principal Investigator

Kaohsiung Veterans General Hospital.

Eligibility Criteria

Inclusion Criteria

  • Patients with prolonged mechanical ventilation and transfer to respiratory care center, age of 20 years or older, at least 1 time of extubation failure or spontaneous breathing trial failure in ICU, stable hemodynamics, no vasopressor use, FiO2 = 0.40 or less, external positive end-expiratory pressure = 5 cmH2O or less, PaO2 \> 60 mmHg, and body temperature \< 38ºC (within 24 hours).

Exclusion Criteria

  • Patients with bronchopleural fistulas, central neurological disorders, hemodialysis, and those with pressure support level already \< 15 cmH2O.

Outcomes

Primary Outcomes

28-day weaning success rate

Time Frame: 28 days

Weaning success was defined as being alive and liberation from MV for more than 48 hours.

Secondary Outcomes

  • Weaning duration(up to 28 days)
  • Weaning success at discharge(up to 123 days)
  • Hospital length of stay(up to 123 days)
  • Hospital mortality(up to 123 days)

Study Sites (1)

Loading locations...

Similar Trials